Resources from the same session
552O - FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel
Presenter: Jenny Seligmann
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
LBA27 - First-line systemic treatment in patients with initially unresectable colorectal cancer liver metastases (CRLM): Overall survival of the phase III CAIRO5 study of the Dutch Colorectal Cancer Group
Presenter: Cornelis Punt
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant 552O and LBA27
Presenter: Dominik Modest
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Webcast
553O - Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of 7 trials
Presenter: Julien Taieb
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
LBA29 - Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial
Presenter: John Chia
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
LBA28 - The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients
Presenter: Sara Lonardi
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant 553O, LBA28 and LBA29
Presenter: Chiara Cremolini
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast